Akinyemiju, T., Moore, J. X., Dibaba, D. T., Pisu, M., Goodman, M., Howard, V. J., … Judd, S. E. (2020). Correction: Association of baseline inflammatory biomarkers with cancer mortality in the REGARDS cohort. Oncotarget, 11(7), 758. https://doi.org/10.18632/oncotarget.27480

Akinyemiju, Tomi, Justin X. Moore, Daniel Tefera Dibaba, Maria Pisu, Michael Goodman, Virginia J. Howard, Monika Safford, et al. “Correction: Association of baseline inflammatory biomarkers with cancer mortality in the REGARDS cohort.” Oncotarget 11, no. 7 (February 18, 2020): 758. https://doi.org/10.18632/oncotarget.27480.

Akinyemiju T, Moore JX, Dibaba DT, Pisu M, Goodman M, Howard VJ, et al. Correction: Association of baseline inflammatory biomarkers with cancer mortality in the REGARDS cohort. Oncotarget. 2020 Feb 18;11(7):758.

Akinyemiju, Tomi, et al. “Correction: Association of baseline inflammatory biomarkers with cancer mortality in the REGARDS cohort.” Oncotarget, vol. 11, no. 7, Feb. 2020, p. 758. Pubmed, doi:10.18632/oncotarget.27480.

Akinyemiju T, Moore JX, Dibaba DT, Pisu M, Goodman M, Howard VJ, Safford M, Gilchrist SC, Cushman M, Long L, Judd SE. Correction: Association of baseline inflammatory biomarkers with cancer mortality in the REGARDS cohort. Oncotarget. 2020 Feb 18;11(7):758.